Berman & Simmons News Articles

  • Patient Safety News: FDA Halts the Sale of Surgical Mesh

    The Food and Drug Administration (FDA) has ordered Boston Scientific and Coloplast, the producers of surgical mesh, to stop selling and distributing its products made for treating pelvic organ prolapse (POP) immediately. This decision was reached after thousands of patients filed suit against the companies, blaming the product for painful and often permanent complications, many requiring further surgery. They include […]

  • Patient Safety News: FDA Deliberates Taking Women’s Surgical Mesh Off the Market

    The FDA is now considering whether synthetic surgical mesh products used to treat pelvic organ prolapse should remain available to patients. There have been 10,390 reports of injury and 77 deaths linked to the product, also commonly known as vaginal mesh. Thousands of women have filed lawsuits against the medical device manufacturers Boston Scientific and Coloplast Corp, citing the faulty […]

  • Patient Safety News: Patients awarded $775 Million for complications caused by Xarelto

    Bayer and Johnson & Johnson, the two manufacturers of the blood thinner Xarelto, will pay $775 million to patients who say they were not informed that the drug could cause deadly bleeding side effects. Xarelto is prescribed to prevent clots that could lead to strokes. There have been 25,000 lawsuits filed against the companies, charging they failed to warn patients […]

  • Patient Safety News: FDA Meets on Breast Implants Associated with Causing Cancer

    The U.S. Food and Drug Administration (FDA) held a two-day meeting in March 2019 to hear from patients, physicians, manufacturers and other experts about the risk that certain breast implants have in causing cancer. The FDA has received notice of 457 cancer cases from women with the implants through last year. The purpose of the hearings is to determine whether […]

Berman & Simmons: No To Racism